MEM 1003

DRUG2 trials

Sponsors

Memory Pharmaceuticals

Conditions

Alzheimer's DiseaseBipolar Disorder With Manic or Mixed Episodes

Phase 2

Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

CompletedNCT00257673

Memory PharmaceuticalsAlzheimer's Disease

Start: 2005-11-30End: 2007-10-31Updated: 2008-05-06

Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder

CompletedNCT00374920

Memory PharmaceuticalsBipolar Disorder With Manic or Mixed Episodes

Start: 2006-09-30End: 2007-03-31Target: 60Updated: 2008-05-06